港股早評:三大指數低開 科技股普跌 地緣政治緊張黃金、石油大漲
中東地緣局勢急劇升溫,風險市場集體走低。港股三大指數低開,恆指跌0.31%,國指跌0.47%,恆生科技指數跌0.95%。盤面上,大型科技股全線下跌市場承壓,快手、網易跌1.7%,阿里巴巴、美團跌超1%,京東、小米、百度均下跌,騰訊逆勢飄紅;連續上漲的創新藥概念股走勢分化,雲頂新耀大跌7%,再鼎醫藥、翰森製藥、藥明康德走低,昨日飆漲超19%的中國生物製藥繼續上漲1.58%;受波音787客機空難影響,航空股普跌,教育股、中資券商股多數走低。另一方面,以色列對伊朗發動打擊,避險情緒升溫,黃金、石油價格飆升,黃金股、石油股上漲明顯,珠峯黃金漲超8%,赤峯黃金漲近7%,中海油、中石油漲超2%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.